Farklı nöromusküler hastalıklarda ayak bileği limitasyonunun yürüme becerisi üzerine etkisi

Amaç: Çalışmanın amacı farklı bölgesel kas zayıflığına sahip iki grupta (proksimal ve distal) ayak bileği limitasyonunun, yürüme becerisi üzerine olan etkisini araştırmak ve karşılaştırmak idi. Yöntem: Çalışmaya Brooke Alt Ekstremite Fonksiyonel Sınıflandırması’na göre devre 1-3, primer olarak proksimal kas tutulumu olan 20 çocuk (yaş ortalaması:9.05±3.1 yıl), ve distal kas tutulumu olan (yaş ortalaması:12.95±3.3 yıl) diğer 20 çocuk olmak üzere, toplam 40 çocuk dahil edildi. Çocukların demografik bilgileri kaydedildi. Ayak bileği eklem limitasyonu gonyometre ile ölçüldü. Yürüme kapasiteleri, 6 dakika yürüme testi (6DYT) ile değerlendirildi. 6 dakikadaki yürüme mesafesi, attıkları tur, adım sayısı, adım uzunlukları ve kadansları kaydedildi.Sonuçlar: Çalışmada ayak bileği dorsifleksiyon limitasyonu ve 6 dakikada yürüdükleri toplam mesafe açısından gruplar arasında fark bulunmadı (p>0.05). 6DYT’nin diğer performans parametreleri açısından, test sırasındaki adım uzunluklarında distal kas tutulumlu grup lehine istatistiksel olarak anlamlı fark bulundu (p

Effect of ankle joint limitation on walking ability in different neuromuscular diseases

Purpose: In this study, we aimed to investigate the impact of the ankle limitation on the walking ability among two groups that have different spatial distribution of the weakness.Methods: In total, 40 children at the levels 1-3 of the Brooke Lower Extremity Scale are included in this study. 20 of them have been diagnosed distal muscle weakness (mean ages: 12.9±3.3 year), and the other 20 have been proximal muscle weakness (mean ages: 9±3.1). The demographic information were recorded. Ankle joint limitation were measured with goniometer. Their ambulatory capacities were evaluated with the 6 minutes walk test (6MWT). Total walking distances in 6 minutes, strolls that taken, step counts, stride lengths, and cadences were saved.Results: There was not any significant difference between the groups with respect to the limitations in ankle joints’ movement and 6 minute total walking distance (p > 0.05). For the other 6MWT walking parametres, there was a statistically significant difference on the stride lengths in the test in favour of (to the good) the group with distal muscle weakness (p

___

  • Farmer SE, Pearce G, Whittall J, Quinlivan RC, Patrick JH. The use of stock orthoses to assist gait in neuromuscular disorders: a pilot study. Prosthet Orthot Int. 2006;30(2):145–54.
  • Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hop- pitt T. Rehabilitation interventions for foot drop in neuromuscu- lar disease. Cochrane Database Syst Rev. 2009;8(3):CD003908.
  • Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4(3):186-97.
  • Otman S, Demirel H, Sade A. Tedavi Hareketlerinde Temel De- ğerlendirme Prensipleri. H.Ü. Fizik Tedavi ve Rehabilitasyon Yük- sekokulu Yayınları; 2003.
  • Aras B. Musküler distrofili olgularda motor fonksiyon ve denge- deki değişikliklerin incelenmesi. Hacettepe Üniversitesi Doktora Tezi; 2007.
  • Eng JJ, Chu KS, Dawson AS, Kim CM, Hepburn KE. Functional walk tests in individuals with stroke: relation to perceived exer- tion and myocardial exertion. Stroke. 2002;33(3):756-61.
  • McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elf- ring GL, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nevre. 2010;41(4):500- 10.
  • Am J. ATS statement: guidelines for the six-minute walk test.ATS Committee on Proficiency Standards for Clinical Pulmonary Fun- ction Laboratories. Respir Crit Care Med. 2002;166(1):111-7.
  • Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, et al. Six-minute walk test in children and adolescents. J Pediatr. 2007;150(7):395-99.
  • Alpar R. Spor Bilimlerinde Uygulamalı İstatistik. Nobel Yayın Da- ğıtımı. 2006.
  • Saguil A. Evaluation of the patient with muscle weakness. Am Fam Physician. 2005;71(7):1327-36.
  • Mastaglia FL, Laing NG. Distal myopathies: clinical and molecu- lar diagnosis and classification. J Neurol Neurosurg Psychiatry. 1999;67(6):703-7.
  • Horlings CG, Küng UM, van Engelen BG, Voermans NC, Hen- gstman GJ, van der Kooi AJ, et al. Balance control in patients with distal versus proximal muscle weakness. Neuroscience. 2009;164(4):1876-86.
  • Horlings CG, van Engelen BG, Allum JH, Bloem BR. A weak balan- ce: the contribution of muscle weakness to postural instability and falls. Nat Clin Pract Neurol. 2008;4(9):504-15.
  • Hsu JD, Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993;288:122- 5.
  • Hyde SA, Filytrup I, Glent S, Kroksmark AK, Salling B, Steffen- sen BF, et al. A randomized comparative study of two methods for controlling Tendo Achillescontracture in Duchenne muscular dystrophy. Neuromuscul Disord. 2000;10(4-5):257-63.
  • Gazendam MG, Hof AL. Averaged EMG profiles in jogging and running at different speeds. Gait Posture. 2007;25(4):604-14.
  • Sutherland DH, Cooper L, Daniel D. The role of the ankle plantar flexors in normal walking. J Bone Joint Surg Am. 1980;62(3):354- 63.
  • Rose KJ, Burns J, North KN. Relationship between foot strength and motor function in preschool-age children. Neuromuscul Di- sord. 2009;19(2):104-7.
  • Carter GT, Abresch RT, Fowler WM, Jr Johnson ER, Kimler DD, McDonald CM. Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil. 1995;74(5):140-49.
  • Burns J, Crosbie J, Hunt A, Ouvrier R. The effect of pes cavus on foot pain and plantar pressure. Clin Biomech. 2005;20(9):877- 82.